A detailed history of New Edge Advisors, LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 586 shares of EBS stock, worth $5,695. This represents 0.0% of its overall portfolio holdings.

Number of Shares
586
Holding current value
$5,695
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$7.72 - $11.97 $4,523 - $7,014
586 New
586 $5,000
Q4 2022

Feb 14, 2023

BUY
$11.0 - $21.45 $1,485 - $2,895
135 New
135 $1,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $485M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.